To get a GLP-1 prescription online in New York, you complete a health questionnaire, a New York-licensed clinician reviews it — usually by secure message, not a scheduled video call — and if they determine treatment is appropriate, a licensed pharmacy fills the prescription and ships it to your address. New York is one of the states where the entire process can happen asynchronously: no drive to a specialist, no waiting room, and for most patients, no video visit at all. See our state page for New York for current availability and pricing, or read on for exactly how the process works and what's specific to New York residents.
The short answer
New York allows a licensed clinician to establish care and prescribe a GLP-1 like semaglutide or tirzepatide entirely through an online intake and secure messaging — no video visit is required by state rule for non-controlled medications like these. The clinician reviewing your case must hold an active New York medical license; an out-of-state license isn't enough. Both compounded and FDA-approved brand-name GLP-1s are available through the same intake, and eligibility is always a clinical decision, never automatic.
How does the online intake work for New York residents?
The mechanics are the same questionnaire-then-review process used everywhere, but two details are New York-specific: who's allowed to review your case, and how nurse practitioners fit in.
- You complete an intake questionnaire. Medical history, current medications, prior GLP-1 use, and your goals — typically 5–10 minutes from a phone or computer.
- A New York-licensed clinician reviews it. New York requires any provider prescribing to a New York resident to hold an active New York medical license — a license from another state doesn't qualify, even for an otherwise identical telehealth visit. Nurse practitioners can also prescribe: under the Nurse Practitioner Modernization Act, an NP with more than 3,600 hours of practice experience can prescribe independently, with no physician agreement required; newer NPs prescribe under a written collaborative agreement with a physician.
- The clinician decides whether treatment is appropriate. This is a clinical judgment based on your history and goals, not a guarantee tied to submitting a form.
- A licensed pharmacy fills the prescription. Compounded preparations are prepared per-patient by a US-licensed compounding pharmacy; FDA-approved brand-name medications are filled by a licensed pharmacy that dispenses the commercially manufactured product.
- It ships to your New York address, typically within 2–3 business days of the pharmacy filling the order — whether you're in New York City or Long Island, or further upstate in Buffalo, Rochester, Syracuse, or Albany, the process and the price are the same.
For the full national walkthrough of each step — including what disqualifies someone and how to vet a provider — see how a GLP-1 prescription online actually works. This piece focuses on what changes when you're a New York resident.
Do I need a video visit in New York?
No. New York is one of the 43 async-first states, where the entire process — intake, clinician review, prescribing decision, and follow-up — can happen by secure message. Under New York Education Law and Department of Health telehealth guidance, a licensed provider may establish the provider-patient relationship and prescribe non-controlled medications like GLP-1s through telehealth, including asynchronous, store-and-forward review of a completed intake, as long as the standard of care is met and informed consent is obtained. GLP-1s are not controlled substances, so New York's separate I-STOP and controlled-substance telemedicine requirements don't add friction here.
That said, "no video call required" isn't a promise that nothing will ever prompt one. Depending on your intake — a complex medical history, an unclear detail worth clarifying — a clinician may follow up by message, ask for a video visit, or request additional labs before prescribing. Most patients complete everything asynchronously, but the clinician's judgment about what your case needs comes first.
Compounded vs. brand-name GLP-1s in New York
Pallas offers both tiers to New York residents through the same intake, and they're worth telling apart:
- Compounded semaglutide and tirzepatide — including a daily oral tablet for semaglutide — prepared per-patient by US-licensed compounding pharmacies under FDCA §503A, prescribed when a New York-licensed clinician documents a patient-specific clinical rationale.
- FDA-approved brand-name medications — Wegovy® and Ozempic® (semaglutide, Novo Nordisk), Zepbound® and Mounjaro® (tirzepatide, Eli Lilly) — the same commercially manufactured products sold at any retail pharmacy, prescribed when a clinician determines they're appropriate. Brand-name prescriptions through Pallas are cash-pay only and are not billed to insurance.
Pallas offers both FDA-approved and compounded medications. Compounded medications are not FDA-approved and are not generic versions of brand-name drugs. Eligibility and treatment are determined by a US-licensed clinician; results vary. Private pay only (no insurance). Operated by Brentmoor, Inc.
Neither tier is "better" in the abstract — which one a clinician recommends depends on your history, goals, and what's clinically appropriate for you, and some patients move between tiers over time. What doesn't change between them is the review itself: both paths go through the same clinician, licensed to prescribe in New York, before anything ships. For a deeper look at how the two compare nationally, see our compounded vs. brand-name GLP-1 guide; for tirzepatide specifically, see how to get tirzepatide online.
Does New York Medicaid cover GLP-1s?
It depends on the reason. New York Medicaid covers GLP-1s including Wegovy® for weight management, typically subject to step therapy and prior authorization — a broader benefit than some states offer. Compounded GLP-1s are not covered under any circumstance. Pallas is a cash-pay telehealth service — no insurance is billed for either tier — so this doesn't change how the intake or pricing works with us, but it's worth knowing if you were weighing the Medicaid route first. For current pricing, see what compounded semaglutide costs and the New York state page and New York cost page.
Is compounded semaglutide available in New York?
Yes — compounded semaglutide is available to eligible New York residents through licensed telehealth. It's prepared per-patient by a US-licensed compounding pharmacy under FDCA §503A, and a New York-licensed clinician must prescribe it based on a documented, patient-specific clinical rationale rather than cost or preference alone. FDA-approved brand-name options are available through the same intake if a compounded preparation isn't the right fit for you.
What should I check before choosing an online provider in New York?
The same red flags apply in New York as everywhere else, plus one New York-specific check:
- A New York medical license, verifiable. Ask, or check the New York State Education Department's license lookup. An out-of-state license doesn't satisfy New York's requirement, no matter how the provider markets itself.
- An intake and clinician review — not just a payment form. If a site skips straight to checkout, it isn't practicing medicine in New York or anywhere else.
- A named, licensed pharmacy. A legitimate provider can tell you which pharmacy — retail or compounding — prepares and ships your medication.
- Verifiable LegitScript certification. LegitScript maintains a public database of certified healthcare merchants. You can look up any provider before paying.
The bottom line
New York residents can get a GLP-1 prescription online through a real clinical process: an intake questionnaire, review by a New York-licensed clinician (physician or NP), a prescribing decision based on your history, and fulfillment through a licensed pharmacy that ships to your address in a few business days. No video visit is required by state rule, both compounded and FDA-approved brand-name options are available, and New York Medicaid covers GLP-1s including Wegovy® for weight management (subject to step therapy and prior authorization) but not compounded preparations. Learn more about GLP-1 treatment at Pallas or start with the New York state page for current specifics.
Trademarks & disclosures
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk. Zepbound® and Mounjaro® are registered trademarks of Eli Lilly and Company. Pallas is not affiliated with, endorsed by, or sponsored by either manufacturer. Brand-name GLP-1 medications dispensed through Pallas are cash-pay only and are not billed to insurance. Prescriptions — brand-name or compounded — are written only when a New York-licensed clinician determines treatment is appropriate.
